Dana-Farber Cancer Institute
hideDana-Farber Cancer Institute is part of a Comprehensive Cancer Center designated by the National Cancer Institute. It is a major affiliate of Harvard Medical School and is located in the Longwood Medical Area in Boston, Massachusetts.
The origins of Dana-Farber date back to 1947 when Sidney Farber, MD, founded Children's Cancer Research Foundation. In 1974, it became known as the Sidney Farber Cancer Institute in honor of its founder. The support of the Charles A. Dana Foundation was acknowledged by incorporating Dana's name in 1983.
Dana-Farber employs about 3,150 people. There are more than 185,000 adult and pediatric patient visits a year, and it is involved in some 200 clinical trials. It is internationally known for its research and clinical excellence. Dana-Farber is a member of the Multiple Myeloma Research Consortium.
In addition to being a principal teaching affiliate of Harvard Medical School, Dana-Farber is also a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a federally designated comprehensive cancer center. Providing advanced training in cancer treatment and research for an international faculty, Dana-Farber conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School and the Partners HealthCare System, including Brigham and Women's Hospital, Children's Hospital, and Massachusetts General Hospital.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and private foundations and individuals contributions. The Jimmy Fund is the principal charity of the Institute named for one of its child patients. The Boston Red Sox adopted the Jimmy Fund as its official charity in 1953 and continues to prominently sponsor the charity.
For more information about Dana-Farber Cancer Institute, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with dana farber cancer institute
Blood type study sheds light on biology of pancreatic cancer
Mar 11, 2009 |
5 / 5 (1) |
0
(PhysOrg.com) -- Offering a novel clue about the basic biology of pancreatic cancer, researchers at Dana-Farber Cancer Institute have confirmed a decades-old discovery of a link between blood type and the ...
Study: Doctor-patient conversations at end of life associated with lower medical expenses
Mar 09, 2009 |
not rated yet |
1
Few physicians are eager to discuss end-of-life care with their patients. Yet such conversations may result in better quality of life for patients and could lower national healthcare expenditures for cancer care alone by ...
Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses
Biology /
Feb 22, 2009 |
5 / 5 (7) |
1
Researchers at the Dana-Farber Cancer Institute, Burnham Institute for Medical Research and the Centers for Disease Control and Prevention have reported the identification of human monoclonal antibodies (mAb) that neutralize ...
Studies offer guide as protein interaction mapping comes of age
Jan 06, 2009 |
5 / 5 (1) |
0
During the past 20 years, researchers have identified thousands of cell protein interactions, with the ultimate goal of inventorying all that occur within cells of various organisms - a comprehensive catalogue known as the ...
Search results for dana farber cancer institute
Study suggests chemotherapy diminishes fertility in breast cancer patients
May 30, 2008 |
not rated yet |
0
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared ...
Exercise improves survival rates for colorectal cancer patients
Dec 14, 2009 |
not rated yet |
0
Men who have been treated for colorectal cancer can reduce their risk of dying from the disease by engaging in regular exercise, according to a new study by researchers at Dana-Farber Cancer Institute. The findings are published ...
Drug combination shrinks breast cancer metastases in brain
Dec 16, 2007 |
5 / 5 (1) |
0
A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber ...
One in ten advanced colon cancer patients worry about prescription drug costs
May 29, 2009 |
not rated yet |
0
The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies ...
Study reveals a reprogrammed role for the androgen receptor
Jul 27, 2009 |
not rated yet |
1
The androgen receptor - a protein ignition switch for prostate cancer cell growth and division - is a master of adaptability. When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, ...
Researchers identify cancer-causing gene in many colon cancers
Sep 14, 2008 |
4.5 / 5 (4) |
1
Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.
New picture of HIV-1's protein jacket identifies target for antibody-based vaccine
Medicine & Health / HIV & AIDS
Jan 10, 2008 |
3.7 / 5 (3) |
0
By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, ...
New blood test greatly reduces false-positives in prostate cancer screening
May 28, 2009 |
5 / 5 (3) |
0
ORLANDO, Fla.--A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, ...
Scientists may have identified new target for HIV vaccine
Medicine & Health / HIV & AIDS
Jan 17, 2008 |
5 / 5 (4) |
0
By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, ...
Black patients with terminal cancer more likely to choose aggressive care at end of life
May 30, 2008 |
not rated yet |
0
Black patients with advanced cancer were more likely than whites to die in a hospital intensive care unit, reflecting a greater preference among blacks for life-extending treatment even in the face of a terminal prognosis, ...
List of search results for dana farber cancer institute
